profit from every $100 of sales.
$0$100
Archimedes Tech SPAC Partners II Co. Warrant
We have no price for Archimedes Tech SPAC Partners II Co. Warrant since 21 October 2026. It may have been taken over, merged or renamed, so the figures below are from then.
$0.83+15.92% today
+417.6% in 1 year
1-year low $0.131-year high $1.85
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $40.20 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Archimedes Tech SPAC Partners II Co. Warrant vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Archimedes Tech SPAC Partners II Co. Warrant | 40.2× · No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads Archimedes Tech SPAC Partners II Co. Warrant's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions | 2025 |
|---|---|
| 0 | |
| – | |
| -1 | |
| -1 | |
| 8 | |
| – | |
| – | |
| – | |
| – |
Balance sheet
| In millions | 2025 |
|---|---|
| Total assets | 241 |
| Cash | 1 |
| Total debt | – |
| Total liabilities | 8 |
| 233 | |
| – | |
| -0.3% | |
| 3.4% |
Cash flow
| In millions | 2025 |
|---|---|
| -1 | |
| – | |
| -1 | |
| Dividends paid | – |
| – | |
| – |
Valuation
- 40.2×
- –
- 0.01
- 1.4×
- 0.0×
- –
- –
- -1.2%
- 2.5%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -0.3%
- 1.7%
- 3.5%
- 3.3%
- -0.3%
- –
Growth
- –
- –
- –
- –
- +305.8%
Financial health
- -1.8×
- 0.00
- 0.0%
- –
- 10.72
- 10.72
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 11%of 668
Bottom 9%of 524
Bottom 9%of 903
Bottom 21%of 938
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
23No pass
Benjamin Graham
47No pass
Philip Fisher
28No pass
Peter Lynch
60Pass
Joel Greenblatt
6No pass
Charlie Munger
19No pass
Terry Smith
19No pass
Questions about Archimedes Tech SPAC Partners II Co. Warrant
Is Archimedes Tech SPAC Partners II Co. Warrant a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Archimedes Tech SPAC Partners II Co. Warrant AI analysis
What does Archimedes Tech SPAC Partners II Co. Warrant do?
Archimedes Tech SPAC Partners II Co. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. It is in Shell Companies.
Does Archimedes Tech SPAC Partners II Co. Warrant pay a dividend?
No. Archimedes Tech SPAC Partners II Co. Warrant does not pay a dividend at the moment.
Is Archimedes Tech SPAC Partners II Co. Warrant stock halal?
Questionable. Archimedes Tech SPAC Partners II Co. Warrant sits in a grey zone: scholars disagree about its industry. How we check
How has Archimedes Tech SPAC Partners II Co. Warrant stock done over the past year?
Up 417.6% over the past twelve months, to $0.83. It traded between $0.13 and $1.85 and is 55.2% below its high.
Who are Archimedes Tech SPAC Partners II Co. Warrant's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with Archimedes Tech SPAC Partners II Co. Warrant's.
Prices: daily closes to Oct 21, 2026. Fundamentals: company reports via invest-like data.